GHGKHKNK Octapeptide (P-5m) Inhibits Metastasis of HCCLM3 Cell Lines via Regulation of MMP-2 Expression in in Vitro and in Vivo Studies
Open Access
- 2 February 2012
- Vol. 17 (2) , 1357-1372
Abstract
P-5m, an octapeptide derived from domain 5 of HKa, was initially found to inhibit the invasion and migration of melanoma cells. The high metastatic potential of melanoma cells was prevented by the HGK motif in the P-5m peptide in vitro and in an experimental lung metastasis model, suggesting that P-5m may play an important role in the regulation of tumor metastasis. The aim of this study was to measure the effect of P-5m on tumor metastasis of human hepatocarcinoma cell line (HCCLM3) in vitro and in vivo in a nude mouse model of hepatocellular carcinoma (HCC), and detect the mechanisms involved in P-5m-induced anti-metastasis. By gelatin zymography, matrix metallo-proteinases 2 (MMP-2) activity in HCCLM3 was dramatically diminished by P-5m peptide. In addition, the migration and metastasis of HCCLM3 cells was also inhibited by the peptide in vitro. In an orthotopic model of HCC in nude mice, P-5m treatment effectively reduced the lung metastasis as well as the expression of MMP-2 in the tumor tissues. Overall, these observations indicate an important role for P-5m peptide in HCC invasion and metastasis, at least partially through modulation MMP-2 expression. These data suggests that P-5m may have therapeutic potential in metastatic human hepatocarcinoma.Keywords
This publication has 28 references indexed in Scilit:
- Enhancement of the cancer targeting specificity of buforin IIb by fusion with an anionic peptide via a matrix metalloproteinases-cleavable linkerPeptides, 2011
- The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targetsSeminars in Cancer Biology, 2011
- MTSS1 a multifunctional protein and its role in cancer invasion and metastasisFrontiers in Bioscience-Scholar, 2011
- The Use of One-Bead One-Compound Combinatorial Library Technology to Discover High-Affinity αvβ3 Integrin and Cancer Targeting Arginine-Glycine-Aspartic Acid Ligands with a Built-in HandleMolecular Cancer Therapeutics, 2010
- Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptorsAmerican Journal of Physiology-Cell Physiology, 2009
- Molecular Imaging of Metastatic PotentialJournal of Nuclear Medicine, 2008
- Hepatocellular carcinoma cell-specific peptide ligand for targeted drug deliveryMolecular Cancer Therapeutics, 2008
- Fifty years of research on the plasma kallikrein-kinin system: From protein structure and function to cell biology and in-vivo pathophysiologyThrombosis and Haemostasis, 2007
- Urokinase-Type Plasminogen Activator Receptor Is Involved in Mediating the Apoptotic Effect of Cleaved High Molecular Weight Kininogen in Human Endothelial CellsCirculation Research, 2004
- Inhibition of Vitronectin-Mediated Haptotaxis and Haptoinvasion of MG-63 Cells by Domain 5 (D5H) of Human High-Molecular-Weight Kininogen and Identification of a Minimal Amino Acid SequenceBiochemical and Biophysical Research Communications, 2001